人工智能开发和报告的要求,用于MRI前列腺癌检测在未经活检的男性:PI-RADS指导委员会,1.0版本

Baris Turkbey¹, Henkjan Huisman¹, Andriy Fedorov¹+12

• ¹From the Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Room B3B85, Bethesda, MD 20892 (B.T.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (H.H.); Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (A.F., C.M.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Md (K.J.M.); Department of Radiology, Weill Cornell Medicine/New York Presbyterian, New York, NY (D.J.M.); Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy (V.P.); Department of Radiology, University of Chicago, Chicago, Ill (A.O.); Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands (I.G.S.); Department of Surgery, Division of Urology, University of Maryland School of Medicine, Baltimore, Md (M.M.S.); Division of Surgery   Interventional Science, University College London, London, UK (C.M.M.); Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK (C.M.M.); Department of Urinary and Vascular Imaging, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France (O.R.); Faculté de Médecine Lyon Est, Université de Lyon, Université Lyon 1, Lyon, France (O.R.); Department of Radiology, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, Cleveland, Ohio (L.K.B.); Paul Strickland Scanner Centre, Mount Vernon Hospital, Middlesex, UK (A.R.P.); Joint Department of Medical Imaging, Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, Toronto, Canada (M.A.H.); and Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (M.A.H.).